CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dr.Reddy's Laboratories Ltd - ADR Company Snapshot
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.

Sales Analysis. Dr.Reddy's Laboratories Ltd reported sales of $2.10 billion for the fiscal year ending March of 2017. This represents a decrease of 10.8% versus 2016, when the company's sales were $2.36 billion. The sales level in 2017 was fairly close to the level five years ago: in 2012, Dr.Reddy's Laboratories Ltd had sales of $2.02 billion.
   
   
 
  Stock Performance Chart for Dr.Reddy's Laboratories Ltd - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 37.28
(Figures in U.S. Dollars)
1 Week -10.0%   13 Weeks -8.7%  
4 Weeks -13.8%   52 Weeks -19.5%  
 
Dr.Reddy's Laboratories Ltd - ADR Key Data:
  Ticker: RDY Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,103,686,460
(Year Ending Jan 2018).
Employees: 22,175
  Currency: U.S. Dollars Market Cap: 6,178,851,061
  Fiscal Yr Ends: March Shares Outstanding: 165,741,713
  Share Type: Ordinary Closely Held Shares: 43,730,699
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.